SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/50748 |
Resumo: | Virus Reference Department, Public Health England. London. United Kingdom. |
id |
CRUZ_fbb8e7c374c0ce4d3341ec8ff3965e97 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/50748 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Hoschler, KatjaIjaz, SamreenAndrews, NickHo, SammyDicks, SteveJegatheesan, KeerthanaPoh, JohnWarrener, LeneshaKankeyan, ThivyaBaawuah, FrancesBeckmann, JoanneOkike, Ifeanichukwu O.Ahmad, ShazaadGarstang, JoannaBrent, Andrew J.Brent, BernadetteAiano, FelicityBrown, Kevin E.Ramsay, Mary E.Brown, DavidParry, John V.Ladhani, Shamez N.Zambon, Maria2022-01-13T14:01:50Z2022-01-13T14:01:50Z2022HOSCHLER, Katja et al. SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements. Microbiology Spectrum, v. 10, n. 1, e00786-21, p. 1-12, Jan. 2022.2165-0497https://www.arca.fiocruz.br/handle/icict/5074810.1128/spectrum.00786-21engAmerican Society for MicrobiologyCOVID-19AnticorposEscolasPesquisasCriançasFluido oralAntibodyCOVID-19SchoolsSurveysChildrenOral fluidSARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurementsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleVirus Reference Department, Public Health England. London. United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.Virus Reference Department, Public Health England. London, United Kingdom.Virus Reference Department, Public Health England. London, United Kingdom / Microbiology Services Laboratory, NHS Blood and Transplant. Bristol, United Kingdom.Virus Reference Department, Public Health England. London, United Kingdom / Microbiology Services Laboratory, NHS Blood and Transplant. Bristol, United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.East London NHS Foundation Trust. London, United Kingdom.Derbyshire Healthcare NHS Foundation Trust. Derby, United Kingdom.Manchester University NHS Foundation Trust. Manchester, United Kingdom.Birmingham Community Healthcare NHS Trust. Aston, United Kingdom.Oxford University Hospitals NHS Foundation Trust. Oxford, United Kingdom / University of Oxford, Oxford. United Kingdom.Oxford University Hospitals NHS Foundation Trust. Oxford, United Kingdom / University of Oxford, Oxford. United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratórios e do Sarampo. Rio de Janeiro, RJ, Brasil.Virus Reference Department, Public Health England. London. United Kingdom.Immunisation and Countermeasures Division, Public Health England. London, United Kingdom / Paediatric Infectious Diseases Research Group, St. George’s University of London. London, United Kingdom.Virus Reference Department, Public Health England. London. United Kingdom.Seroepidemiological studies to monitor antibody kinetics are important for assessing the extent and spread of SARS-CoV-2 in a population. Noninvasive sampling methods are advantageous for reducing the need for venipuncture, which may be a barrier to investigations, particularly in pediatric populations. Oral fluids are obtained by gingivacrevicular sampling from children and adults and are very well accepted. Enzyme immunoassays (EIAs) based on these samples have acceptable sensitivity and specificity compared to conventional serum-based antibody EIAs and are suitable for population-based surveillance. We describe the development and evaluation of SARS-CoV-2 IgG EIAs using SARSCoV- 2 viral nucleoprotein (NP) and spike (S) proteins in IgG isotype capture format and an indirect receptor-binding-domain (RBD) IgG EIA, intended for use in children as a primary endpoint. All three assays were assessed using a panel of 1,999 paired serum and oral fluids from children and adults participating in school SARS-CoV-2 surveillance studies during and after the first and second pandemic wave in the United Kingdom. The anti-NP IgG capture assay was the best candidate, with an overall sensitivity of 75% (95% confidence interval [CI]: 71 to 79%) and specificity of 99% (95% CI: 78 to 99%) compared with paired serum antibodies. Sensitivity observed in children (80%, 95% CI: 71 to 88%) was higher than that in adults (67%, CI: 60% to 74%). Oral fluid assays (OF) using spike protein and RBD antigens were also 99% specific and achieved reasonable but lower sensitivity in the target population (78%, 95% CI [68% to 86%] and 53%, 95% CI [43% to 64%], respectively).info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/50748/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALDavidBrown_KatiaHoschler_etal_IOC_2022.pdfDavidBrown_KatiaHoschler_etal_IOC_2022.pdfapplication/pdf1354207https://www.arca.fiocruz.br/bitstream/icict/50748/2/DavidBrown_KatiaHoschler_etal_IOC_2022.pdf600efc1bca3730d204618d5fc4a270bfMD52icict/507482022-01-13 12:04:56.736oai:www.arca.fiocruz.br:icict/50748Q0VTU8ODTyBOw4NPIEVYQ0xVU0lWQSBERSBESVJFSVRPUyBBVVRPUkFJUwoKQW8gYWNlaXRhciBvcyBURVJNT1MgZSBDT05EScOHw5VFUyBkZXN0YSBDRVNTw4NPLCBvIEFVVE9SIGUvb3UgVElUVUxBUiBkZSBkaXJlaXRvcwphdXRvcmFpcyBzb2JyZSBhIE9CUkEgZGUgcXVlIHRyYXRhIGVzdGUgZG9jdW1lbnRvOgoKKDEpIENFREUgZSBUUkFOU0ZFUkUsIHRvdGFsIGUgZ3JhdHVpdGFtZW50ZSwgw6AgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaLCBlbQpjYXLDoXRlciBwZXJtYW5lbnRlLCBpcnJldm9nw6F2ZWwgZSBOw4NPIEVYQ0xVU0lWTywgdG9kb3Mgb3MgZGlyZWl0b3MgcGF0cmltb25pYWlzIE7Dg08KQ09NRVJDSUFJUyBkZSB1dGlsaXphw6fDo28gZGEgT0JSQSBhcnTDrXN0aWNhIGUvb3UgY2llbnTDrWZpY2EgaW5kaWNhZGEgYWNpbWEsIGluY2x1c2l2ZSBvcyBkaXJlaXRvcwpkZSB2b3ogZSBpbWFnZW0gdmluY3VsYWRvcyDDoCBPQlJBLCBkdXJhbnRlIHRvZG8gbyBwcmF6byBkZSBkdXJhw6fDo28gZG9zIGRpcmVpdG9zIGF1dG9yYWlzLCBlbQpxdWFscXVlciBpZGlvbWEgZSBlbSB0b2RvcyBvcyBwYcOtc2VzOwoKKDIpIEFDRUlUQSBxdWUgYSBjZXNzw6NvIHRvdGFsIG7Do28gZXhjbHVzaXZhLCBwZXJtYW5lbnRlIGUgaXJyZXZvZ8OhdmVsIGRvcyBkaXJlaXRvcyBhdXRvcmFpcwpwYXRyaW1vbmlhaXMgbsOjbyBjb21lcmNpYWlzIGRlIHV0aWxpemHDp8OjbyBkZSBxdWUgdHJhdGEgZXN0ZSBkb2N1bWVudG8gaW5jbHVpLCBleGVtcGxpZmljYXRpdmFtZW50ZSwKb3MgZGlyZWl0b3MgZGUgZGlzcG9uaWJpbGl6YcOnw6NvIGUgY29tdW5pY2HDp8OjbyBww7pibGljYSBkYSBPQlJBLCBlbSBxdWFscXVlciBtZWlvIG91IHZlw61jdWxvLAppbmNsdXNpdmUgZW0gUmVwb3NpdMOzcmlvcyBEaWdpdGFpcywgYmVtIGNvbW8gb3MgZGlyZWl0b3MgZGUgcmVwcm9kdcOnw6NvLCBleGliacOnw6NvLCBleGVjdcOnw6NvLApkZWNsYW1hw6fDo28sIHJlY2l0YcOnw6NvLCBleHBvc2nDp8OjbywgYXJxdWl2YW1lbnRvLCBpbmNsdXPDo28gZW0gYmFuY28gZGUgZGFkb3MsIHByZXNlcnZhw6fDo28sIGRpZnVzw6NvLApkaXN0cmlidWnDp8OjbywgZGl2dWxnYcOnw6NvLCBlbXByw6lzdGltbywgdHJhZHXDp8OjbywgZHVibGFnZW0sIGxlZ2VuZGFnZW0sIGluY2x1c8OjbyBlbSBub3ZhcyBvYnJhcyBvdQpjb2xldMOibmVhcywgcmV1dGlsaXphw6fDo28sIGVkacOnw6NvLCBwcm9kdcOnw6NvIGRlIG1hdGVyaWFsIGRpZMOhdGljbyBlIGN1cnNvcyBvdSBxdWFscXVlciBmb3JtYSBkZQp1dGlsaXphw6fDo28gbsOjbyBjb21lcmNpYWw7CgooMykgUkVDT05IRUNFIHF1ZSBhIGNlc3PDo28gYXF1aSBlc3BlY2lmaWNhZGEgY29uY2VkZSDDoCBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPCkNSVVogbyBkaXJlaXRvIGRlIGF1dG9yaXphciBxdWFscXVlciBwZXNzb2Eg4oCTIGbDrXNpY2Egb3UganVyw61kaWNhLCBww7pibGljYSBvdSBwcml2YWRhLCBuYWNpb25hbCBvdQplc3RyYW5nZWlyYSDigJMgYSBhY2Vzc2FyIGUgdXRpbGl6YXIgYW1wbGFtZW50ZSBhIE9CUkEsIHNlbSBleGNsdXNpdmlkYWRlLCBwYXJhIHF1YWlzcXVlcgpmaW5hbGlkYWRlcyBuw6NvIGNvbWVyY2lhaXM7CgooNCkgREVDTEFSQSBxdWUgYSBvYnJhIMOpIGNyaWHDp8OjbyBvcmlnaW5hbCBlIHF1ZSDDqSBvIHRpdHVsYXIgZG9zIGRpcmVpdG9zIGFxdWkgY2VkaWRvcyBlIGF1dG9yaXphZG9zLApyZXNwb25zYWJpbGl6YW5kby1zZSBpbnRlZ3JhbG1lbnRlIHBlbG8gY29udGXDumRvIGUgb3V0cm9zIGVsZW1lbnRvcyBxdWUgZmF6ZW0gcGFydGUgZGEgT0JSQSwKaW5jbHVzaXZlIG9zIGRpcmVpdG9zIGRlIHZveiBlIGltYWdlbSB2aW5jdWxhZG9zIMOgIE9CUkEsIG9icmlnYW5kby1zZSBhIGluZGVuaXphciB0ZXJjZWlyb3MgcG9yCmRhbm9zLCBiZW0gY29tbyBpbmRlbml6YXIgZSByZXNzYXJjaXIgYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVogZGUKZXZlbnR1YWlzIGRlc3Blc2FzIHF1ZSB2aWVyZW0gYSBzdXBvcnRhciwgZW0gcmF6w6NvIGRlIHF1YWxxdWVyIG9mZW5zYSBhIGRpcmVpdG9zIGF1dG9yYWlzIG91CmRpcmVpdG9zIGRlIHZveiBvdSBpbWFnZW0sIHByaW5jaXBhbG1lbnRlIG5vIHF1ZSBkaXogcmVzcGVpdG8gYSBwbMOhZ2lvIGUgdmlvbGHDp8O1ZXMgZGUgZGlyZWl0b3M7CgooNSkgQUZJUk1BIHF1ZSBjb25oZWNlIGEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTwpPU1dBTERPIENSVVogZSBhcyBkaXJldHJpemVzIHBhcmEgbyBmdW5jaW9uYW1lbnRvIGRvIHJlcG9zaXTDs3JpbyBpbnN0aXR1Y2lvbmFsIEFSQ0EuCgpBIFBvbMOtdGljYSBJbnN0aXR1Y2lvbmFsIGRlIEFjZXNzbyBBYmVydG8gZGEgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaIHJlc2VydmEKZXhjbHVzaXZhbWVudGUgYW8gQVVUT1Igb3MgZGlyZWl0b3MgbW9yYWlzIGUgb3MgdXNvcyBjb21lcmNpYWlzIHNvYnJlIGFzIG9icmFzIGRlIHN1YSBhdXRvcmlhCmUvb3UgdGl0dWxhcmlkYWRlLCBzZW5kbyBvcyB0ZXJjZWlyb3MgdXN1w6FyaW9zIHJlc3BvbnPDoXZlaXMgcGVsYSBhdHJpYnVpw6fDo28gZGUgYXV0b3JpYSBlIG1hbnV0ZW7Dp8OjbwpkYSBpbnRlZ3JpZGFkZSBkYSBPQlJBIGVtIHF1YWxxdWVyIHV0aWxpemHDp8Ojby4KCkEgUG9sw610aWNhIEluc3RpdHVjaW9uYWwgZGUgQWNlc3NvIEFiZXJ0byBkYSBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVoKcmVzcGVpdGEgb3MgY29udHJhdG9zIGUgYWNvcmRvcyBwcmVleGlzdGVudGVzIGRvcyBBdXRvcmVzIGNvbSB0ZXJjZWlyb3MsIGNhYmVuZG8gYW9zIEF1dG9yZXMKaW5mb3JtYXIgw6AgSW5zdGl0dWnDp8OjbyBhcyBjb25kacOnw7VlcyBlIG91dHJhcyByZXN0cmnDp8O1ZXMgaW1wb3N0YXMgcG9yIGVzdGVzIGluc3RydW1lbnRvcy4KRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-01-13T15:04:56Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements |
title |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements |
spellingShingle |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements Hoschler, Katja COVID-19 Anticorpos Escolas Pesquisas Crianças Fluido oral Antibody COVID-19 Schools Surveys Children Oral fluid |
title_short |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements |
title_full |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements |
title_fullStr |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements |
title_full_unstemmed |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements |
title_sort |
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements |
author |
Hoschler, Katja |
author_facet |
Hoschler, Katja Ijaz, Samreen Andrews, Nick Ho, Sammy Dicks, Steve Jegatheesan, Keerthana Poh, John Warrener, Lenesha Kankeyan, Thivya Baawuah, Frances Beckmann, Joanne Okike, Ifeanichukwu O. Ahmad, Shazaad Garstang, Joanna Brent, Andrew J. Brent, Bernadette Aiano, Felicity Brown, Kevin E. Ramsay, Mary E. Brown, David Parry, John V. Ladhani, Shamez N. Zambon, Maria |
author_role |
author |
author2 |
Ijaz, Samreen Andrews, Nick Ho, Sammy Dicks, Steve Jegatheesan, Keerthana Poh, John Warrener, Lenesha Kankeyan, Thivya Baawuah, Frances Beckmann, Joanne Okike, Ifeanichukwu O. Ahmad, Shazaad Garstang, Joanna Brent, Andrew J. Brent, Bernadette Aiano, Felicity Brown, Kevin E. Ramsay, Mary E. Brown, David Parry, John V. Ladhani, Shamez N. Zambon, Maria |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Hoschler, Katja Ijaz, Samreen Andrews, Nick Ho, Sammy Dicks, Steve Jegatheesan, Keerthana Poh, John Warrener, Lenesha Kankeyan, Thivya Baawuah, Frances Beckmann, Joanne Okike, Ifeanichukwu O. Ahmad, Shazaad Garstang, Joanna Brent, Andrew J. Brent, Bernadette Aiano, Felicity Brown, Kevin E. Ramsay, Mary E. Brown, David Parry, John V. Ladhani, Shamez N. Zambon, Maria |
dc.subject.other.pt_BR.fl_str_mv |
COVID-19 Anticorpos Escolas Pesquisas Crianças Fluido oral |
topic |
COVID-19 Anticorpos Escolas Pesquisas Crianças Fluido oral Antibody COVID-19 Schools Surveys Children Oral fluid |
dc.subject.en.pt_BR.fl_str_mv |
Antibody COVID-19 Schools Surveys Children Oral fluid |
description |
Virus Reference Department, Public Health England. London. United Kingdom. |
publishDate |
2022 |
dc.date.accessioned.fl_str_mv |
2022-01-13T14:01:50Z |
dc.date.available.fl_str_mv |
2022-01-13T14:01:50Z |
dc.date.issued.fl_str_mv |
2022 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
HOSCHLER, Katja et al. SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements. Microbiology Spectrum, v. 10, n. 1, e00786-21, p. 1-12, Jan. 2022. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/50748 |
dc.identifier.issn.pt_BR.fl_str_mv |
2165-0497 |
dc.identifier.doi.none.fl_str_mv |
10.1128/spectrum.00786-21 |
identifier_str_mv |
HOSCHLER, Katja et al. SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements. Microbiology Spectrum, v. 10, n. 1, e00786-21, p. 1-12, Jan. 2022. 2165-0497 10.1128/spectrum.00786-21 |
url |
https://www.arca.fiocruz.br/handle/icict/50748 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
American Society for Microbiology |
publisher.none.fl_str_mv |
American Society for Microbiology |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/50748/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/50748/2/DavidBrown_KatiaHoschler_etal_IOC_2022.pdf |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 600efc1bca3730d204618d5fc4a270bf |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798324713772023808 |